Ans Evaluates Inclusion of Treatment for Patients with Lupus
Summary by Globo
1 Articles
1 Articles
The National Supplementary Health Agency (ANS) has opened public consultation No. 158 to evaluate the inclusion of a new therapeutic option for adult patients (over 18 years of age) with systemic lupus erythematosus (SLE) who do not respond adequately to conventional therapies. Contributions from patients, healthcare professionals, and the general public can be submitted until July 29, 2025.
·Brazil
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium